ImmuCell Corp (ICCC) stock
ICCCNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/303% above fair value
$11.33−0.09 (-0.79%)
Close on Nov 17, 2026Market cap $102.90MP/E 141.6Yield –
ImmuCell market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
ImmuCell's market cap was $92.55M on Nov 11, 2026, against $43.78M a year earlier. Over the last 5 years it ranged from $28.28M to $101.41M, with a median of $54.46M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $92.55M | +66.4% |
| 2025 | Dec 31, 2025 | $55.63M | +22.3% |
| 2024 | Dec 31, 2024 | $45.49M | +15.4% |
| 2023 | Dec 29, 2023 | $39.43M | -16.6% |
| 2022 | Dec 30, 2022 | $47.26M | -23.7% |
| 2021 | Dec 31, 2021 | $61.94M | +44.3% |
| 2020 | Dec 31, 2020 | $42.92M | +15.6% |
| 2019 | Dec 31, 2019 | $37.13M | -3.9% |
| 2018 | Dec 31, 2018 | $38.65M | -13.0% |
| 2017 | Dec 29, 2017 | $44.40M | +91.3% |
| 2016 | Dec 30, 2016 | $23.21M | -1.6% |
| 2015 | Dec 31, 2015 | $23.59M | +58.4% |
| 2014 | Dec 31, 2014 | $14.89M | +13.0% |
| 2013 | Dec 31, 2013 | $13.18M | +7.6% |
| 2012 | Dec 31, 2012 | $12.25M | -11.4% |
| 2011 | Dec 30, 2011 | $13.83M | +46.1% |
| 2010 | Dec 31, 2010 | $9.47M | – |
See a number that looks wrong?